Dupilumab Effects Against Aeroallergen Challenge — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dupilumab Effects Against Aeroallergen Challenge — Stella

Recruiting

Back to Asthma, Allergic trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Biogenics Research Chamber, San Antonio, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Key details

Phase

Safety & dosing

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID), Regeneron Pharmaceuticals

Enrollment target

~88 participants

Started

March 2023

Primary completion

November 2026

Age range

18 Years – 65 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov